Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future

Lung cancer is one of the major causes of cancer related mortality worldwide. Brain metastases (BM) complicate clinical evolution of non-small cell lung cancer (NSCLC) in approximately 25–40% of cases, adversely influencing quality of life (QoL) and overall survival (OS). Systemic therapy remains th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Lung Cancer Res
Autors principals: Proto, Claudia, Imbimbo, Martina, Gallucci, Rosaria, Brissa, Angela, Signorelli, Diego, Vitali, Milena, Macerelli, Marianna, Corrao, Giulia, Ganzinelli, Monica, Greco, Francesca Gabriella, Garassino, Marina Chiara, Lo Russo, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2016
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5233868/
https://ncbi.nlm.nih.gov/pubmed/28149752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2016.10.16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars